Form D — CND Life Sciences, Inc.

0001841099-25-000001 · filed Mar 6, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $7,500,000
Reported amount sold: $3,514,565
Minimum investment: $25,000
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: CND Life Sciences, Inc.
CIK: 1841099
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 9165 E. DEL CAMINO DRIVE
SCOTTSDALE, AZ 85258-4381
Phone: 617-223-1585

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Richard J. Morello · Executive Officer

Atlanta, GA Find on LinkedIn ↗
Todd Levine · Executive Officer

Paradise Valley, AZ Find on LinkedIn ↗
Peter Harris · Executive Officer

Brookline, MA Find on LinkedIn ↗
Enrique Carrazana · Director

Coral Gables, FL Find on LinkedIn ↗
Christopher Gibbons · Director

Brookline, MA Find on LinkedIn ↗
Jack Seaver · Director

New York, NY Find on LinkedIn ↗

Other filings from this issuer

View the original filing on SEC EDGAR ↗